Qdenga tetravalent dengue vaccine protecting against all 4 dengue virus serotypes in tropical destinations for travellers aged 4 and older.
Dengue fever is a mosquito-borne viral infection caused by four distinct dengue virus serotypes (DENV 1–4) transmitted by daytime-biting Aedes aegypti and Aedes albopictus mosquitoes. Widely endemic in tropical and subtropical regions of Southeast Asia, the Caribbean, Central and South America, the Pacific, and Africa, dengue causes severe flu-like symptoms including sudden high fever, intense retro-orbital (behind the eye) headache, muscle and joint pain ('breakbone fever'), nausea, and rash. A second infection with a different serotype significantly increases the risk of severe dengue (dengue hemorrhagic fever). Qdenga is a modern tetravalent live-attenuated dengue vaccine approved by the UK MHRA and EMA for individuals aged 4 and older, regardless of prior dengue infection history. The schedule consists of two subcutaneous doses given 3 months apart.
Your consultation is carried out in a soundproof, private consultation suite by a qualified healthcare professional.
Your consultation begins in a soundproof, private clinic room inside the pharmacy. Your pharmacist reviews your symptom history, existing medications, and individual requirements.
Your clinician carries out diagnostic checks or vital signs triage tailored to Dengue Fever Vaccine in line with UK clinical standards and NICE protocols.
If treatment is clinically indicated, your prescribing pharmacist issues the prescription and supplies or administers your treatment on the spot.
You will receive comprehensive instructions on recovery, expected timelines, and when to seek medical advice. An electronic clinical notification is shared with your registered NHS GP practice.
Single dose administered annually ahead of the winter flu season. Immunity develops in approximately 10–14 days.
If symptoms persist, fail to improve within the expected timeframe, or if regular monitoring is required, book a follow-up consultation with your pharmacy team or contact your GP.
This is a private clinical service provided by accredited independent pharmacist prescribers. You receive direct access without GP referral or waiting lists, with transparent upfront pricing.
All private consultations include face-to-face evaluation in a private suite, diagnostic triage, prescribing assessment, and aftercare guidance. Zero hidden booking fees.
376 BARKING ROAD, PLAISTOW, LONDON • E13 8HL
625-627 ROMAN ROAD, LONDON • E3 2RN
197-199 ROMAN ROAD, LONDON, BETHNAL GREEN, E2 0QY, LONDON • E2 0QY
Follow these simple steps before attending the clinic:
Clinical advice for ongoing recovery and support:
Clinical guidance on consultations, eligibility, and prescription dispensing.
NextDoorClinic content is developed in collaboration with registered UK pharmacy prescribers and based on evidence-based UK clinical commissioning standards and clinical practice guidance:
